Tuberculosis Notification Trends and Treatment Outcomes in Penitentiary and Civilian Health Care Sectors in the WHO European Region.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
10 09 2021
Historique:
received: 29 07 2021
revised: 06 09 2021
accepted: 07 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 3 11 2021
Statut: epublish

Résumé

Tuberculosis (TB) morbidity in penitentiary sectors is one of the major barriers to ending TB in the World Health Organization (WHO) European Region. a comparative analysis of TB notification rates during 2014-2018 and of treatment outcomes in the civilian and penitentiary sectors in the WHO European Region, with an assessment of risks of developing TB among people experience incarceration. in the WHO European Region, incident TB rates in inmates were 4-24 times higher than in the civilian population. In 12 eastern Europe and central Asia (EECA) countries, inmates compared to civilians had higher relative risks of developing TB (RR = 25) than in the rest of the region (RR = 11), with the highest rates reported in inmates in Azerbaijan, Kazakhstan, Kyrgyzstan, Republic of Moldova, Russian Federation, and Ukraine. The average annual change in TB notification rates between 2014 and 2018 was -7.0% in the civilian sector and -10.9% in the penitentiary sector. A total of 15 countries achieved treatment success rates of over 85% for new penitentiary sector TB patients, the target for the WHO European Region. In 10 countries, there were no significant differences in treatment outcomes between civilian and penitentiary sectors. 42 out of 53 (79%) WHO European Region countries reported TB data for the selected time periods. Most countries in the region achieved a substantial decline in TB burden in prisons, which indicates the effectiveness of recent interventions in correctional institutions. Nevertheless, people who experience incarceration remain an at-risk population for acquiring infection, developing active disease and unfavourable treatment outcomes. Therefore, TB prevention and care practices in inmates need to be improved.

Identifiants

pubmed: 34574488
pii: ijerph18189566
doi: 10.3390/ijerph18189566
pmc: PMC8466779
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

Cad Saude Publica. 2015 Jun;31(6):1127-30
pubmed: 26200361
PLoS One. 2014 Jan 20;9(1):e86046
pubmed: 24465861
N Engl J Med. 2007 Jan 11;356(2):157-65
pubmed: 17215533
Jundishapur J Microbiol. 2014 Dec 01;7(12):e18872
pubmed: 25741435
Lancet. 2016 Sep 10;388(10049):1115-1126
pubmed: 27427456
Int J Tuberc Lung Dis. 2006 Nov;10(11):1215-23
pubmed: 17131779
Int J Tuberc Lung Dis. 2013 Jan;17(1):4-5
pubmed: 23231999
Eur Respir J. 2011 Oct;38(4):752-4
pubmed: 21965498
Health Hum Rights. 2011 Dec 15;13(2):E73-81
pubmed: 22773034
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13280-5
pubmed: 18728189
J Infect Dis. 2012 May 15;205 Suppl 2:S274-83
pubmed: 22448026
Am J Respir Crit Care Med. 1997 Feb;155(2):719-25
pubmed: 9032218
Int J Infect Dis. 2015 Mar;32:111-7
pubmed: 25809766
PLoS Med. 2010 Dec 21;7(12):e1000381
pubmed: 21203587
Thorax. 2005 Feb;60(2):130-5
pubmed: 15681501
Rev Esp Sanid Penit. 2018 Sep-Dec;20(3):111-120
pubmed: 30908566
Lancet Public Health. 2021 May;6(5):e300-e308
pubmed: 33765455
Int J Tuberc Lung Dis. 2016 May;20(5):645-51
pubmed: 27084819

Auteurs

Andrei Dadu (A)

Regional Office for Europe, World Health Organization, 2100 Copenhagen, Denmark.

Ana Ciobanu (A)

Health Primary Care Department, University of Medicine and Pharmacy 'N. Testemitanu', 2004 Chisinau, Moldova.

Araksya Hovhannesyan (A)

Regional Office for Europe, World Health Organization, 2100 Copenhagen, Denmark.

Natavan Alikhanova (N)

Main Medical Department of the Ministry of Justice of Azerbaijan Republic, Baku AZ1000, Azerbaijan.

Oleksandr Korotych (O)

Regional Office for Europe, World Health Organization, 2100 Copenhagen, Denmark.

Elmira Gurbanova (E)

WHO Collaborating Centre on Prevention and Control of TB in Prisons, Baku AZ1000, Azerbaijan.

Rafael Mehdiyev (R)

Main Medical Department of the Ministry of Justice of Azerbaijan Republic, Baku AZ1000, Azerbaijan.

Svetlana Doltu (S)

Council for Preventing and Eliminating Discrimination and Ensuring Equality, 2004 Chisinau, Moldova.

Ogtay Gozalov (O)

Regional Office for Europe, World Health Organization, 2100 Copenhagen, Denmark.

Sevim Ahmedov (S)

United States Agency for International Development, Arlington, VA 22202, USA.

Masoud Dara (M)

Regional Office for Europe, World Health Organization, 2100 Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH